Předmět: |
|
Zdroj: |
Clinical Oncology Week; 8/15/2023, p737-737, 1p |
Abstrakt: |
Keywords: Alkylating Agents; Amebicides; Antiinfectives; Antimalarial Agents; Antineoplastics; Antirheumatics; Cancer; Chloroquine Therapy; Drugs and Therapies; Glioblastomas; Health and Medicine; Hydrazines; Hydrazones; Oncology; Pharmaceuticals; Temozolomide Therapy EN Alkylating Agents Amebicides Antiinfectives Antimalarial Agents Antineoplastics Antirheumatics Cancer Chloroquine Therapy Drugs and Therapies Glioblastomas Health and Medicine Hydrazines Hydrazones Oncology Pharmaceuticals Temozolomide Therapy 737 737 1 08/14/23 20230815 NES 230815 2023 AUG 14 (NewsRx) -- By a News Reporter-Staff News Editor at Clinical Oncology Week -- Research findings on glioblastomas are discussed in a new report. For more information on this research see: Autophagy Inhibition with Chloroquine Increased Pro-Apoptotic Potential of New Aziridine-Hydrazide Hydrazone Derivatives against Glioblastoma Cells. [Extracted from the article] |
Databáze: |
Complementary Index |
Externí odkaz: |
|